vs
Orthofix Medical Inc.(OFIX)与Planet Fitness, Inc.(PLNT)财务数据对比。点击上方公司名可切换其他公司
Planet Fitness, Inc.的季度营收约是Orthofix Medical Inc.的1.7倍($376.3M vs $219.9M),Planet Fitness, Inc.净利率更高(16.0% vs -1.0%,领先17.1%),Planet Fitness, Inc.同比增速更快(10.5% vs 2.0%),Planet Fitness, Inc.自由现金流更多($59.0M vs $16.8M),过去两年Planet Fitness, Inc.的营收复合增速更高(23.2% vs 8.0%)
Orthofix医疗是全球知名骨科医疗器械企业,专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品,服务全球多地的骨科医师与医疗机构,致力于提升肌肉骨骼疾病患者的诊疗效果。
Planet Fitness Inc.是总部位于美国新罕布什尔州汉普顿的健身中心特许经营商及运营商,目前在全球拥有约2715家门店,覆盖美国、加拿大、巴拿马、墨西哥、西班牙、澳大利亚等国,是全球规模最大的健身俱乐部特许经营品牌之一,主打「无评判空间」理念,面向所有健身水平的用户开放。
OFIX vs PLNT — 直观对比
营收规模更大
PLNT
是对方的1.7倍
$219.9M
营收增速更快
PLNT
高出8.5%
2.0%
净利率更高
PLNT
高出17.1%
-1.0%
自由现金流更多
PLNT
多$42.1M
$16.8M
两年增速更快
PLNT
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $219.9M | $376.3M |
| 净利润 | $-2.2M | $60.4M |
| 毛利率 | 71.1% | 76.0% |
| 营业利润率 | 0.2% | 28.2% |
| 净利率 | -1.0% | 16.0% |
| 营收同比 | 2.0% | 10.5% |
| 净利润同比 | 92.4% | 28.3% |
| 每股收益(稀释后) | $-0.05 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
OFIX
PLNT
| Q4 25 | $219.9M | $376.3M | ||
| Q3 25 | $205.6M | $330.3M | ||
| Q2 25 | $203.1M | $340.9M | ||
| Q1 25 | $193.6M | $276.7M | ||
| Q4 24 | $215.7M | $340.4M | ||
| Q3 24 | $196.6M | $292.2M | ||
| Q2 24 | $198.6M | $300.9M | ||
| Q1 24 | $188.6M | $248.0M |
净利润
OFIX
PLNT
| Q4 25 | $-2.2M | $60.4M | ||
| Q3 25 | $-22.8M | $58.8M | ||
| Q2 25 | $-14.1M | $58.0M | ||
| Q1 25 | $-53.1M | $41.9M | ||
| Q4 24 | $-29.1M | $47.1M | ||
| Q3 24 | $-27.4M | $42.0M | ||
| Q2 24 | $-33.4M | $48.6M | ||
| Q1 24 | $-36.0M | $34.3M |
毛利率
OFIX
PLNT
| Q4 25 | 71.1% | 76.0% | ||
| Q3 25 | 72.2% | 82.4% | ||
| Q2 25 | 68.7% | 82.6% | ||
| Q1 25 | 62.8% | 91.9% | ||
| Q4 24 | 69.0% | 76.4% | ||
| Q3 24 | 68.7% | 84.4% | ||
| Q2 24 | 67.8% | 82.7% | ||
| Q1 24 | 67.5% | 92.3% |
营业利润率
OFIX
PLNT
| Q4 25 | 0.2% | 28.2% | ||
| Q3 25 | -8.3% | 32.4% | ||
| Q2 25 | -7.9% | 30.0% | ||
| Q1 25 | -25.2% | 28.6% | ||
| Q4 24 | -5.3% | 26.4% | ||
| Q3 24 | -9.6% | 27.8% | ||
| Q2 24 | -12.5% | 29.0% | ||
| Q1 24 | -15.6% | 26.5% |
净利率
OFIX
PLNT
| Q4 25 | -1.0% | 16.0% | ||
| Q3 25 | -11.1% | 17.8% | ||
| Q2 25 | -6.9% | 17.0% | ||
| Q1 25 | -27.4% | 15.1% | ||
| Q4 24 | -13.5% | 13.8% | ||
| Q3 24 | -13.9% | 14.4% | ||
| Q2 24 | -16.8% | 16.2% | ||
| Q1 24 | -19.1% | 13.8% |
每股收益(稀释后)
OFIX
PLNT
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.57 | — | ||
| Q2 25 | $-0.36 | — | ||
| Q1 25 | $-1.35 | — | ||
| Q4 24 | $-0.76 | — | ||
| Q3 24 | $-0.71 | — | ||
| Q2 24 | $-0.88 | — | ||
| Q1 24 | $-0.95 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $452.4M |
| 总债务越低越好 | — | $2.5B |
| 股东权益账面价值 | $450.0M | $-482.8M |
| 总资产 | $850.6M | $3.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
OFIX
PLNT
| Q4 25 | $82.0M | $452.4M | ||
| Q3 25 | $62.9M | $443.4M | ||
| Q2 25 | $65.6M | $442.7M | ||
| Q1 25 | $58.0M | $453.6M | ||
| Q4 24 | $83.2M | $407.3M | ||
| Q3 24 | $30.1M | $407.4M | ||
| Q2 24 | $26.4M | $350.2M | ||
| Q1 24 | $27.0M | $395.1M |
总债务
OFIX
PLNT
| Q4 25 | — | $2.5B | ||
| Q3 25 | $157.2M | $2.2B | ||
| Q2 25 | $157.0M | $2.2B | ||
| Q1 25 | $156.9M | $2.2B | ||
| Q4 24 | $157.0M | $2.2B | ||
| Q3 24 | $118.5M | $2.2B | ||
| Q2 24 | $118.0M | $2.2B | ||
| Q1 24 | $118.2M | $2.0B |
股东权益
OFIX
PLNT
| Q4 25 | $450.0M | $-482.8M | ||
| Q3 25 | $442.5M | $-194.8M | ||
| Q2 25 | $458.3M | $-158.7M | ||
| Q1 25 | $458.3M | $-219.9M | ||
| Q4 24 | $503.1M | $-215.4M | ||
| Q3 24 | $525.9M | $-266.1M | ||
| Q2 24 | $546.0M | $-317.7M | ||
| Q1 24 | $570.3M | $-96.4M |
总资产
OFIX
PLNT
| Q4 25 | $850.6M | $3.1B | ||
| Q3 25 | $832.6M | $3.1B | ||
| Q2 25 | $837.2M | $3.1B | ||
| Q1 25 | $823.1M | $3.1B | ||
| Q4 24 | $893.3M | $3.1B | ||
| Q3 24 | $867.9M | $3.0B | ||
| Q2 24 | $882.0M | $3.0B | ||
| Q1 24 | $906.0M | $3.0B |
负债/权益比
OFIX
PLNT
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $27.7M | $109.1M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $59.0M |
| 自由现金流率自由现金流/营收 | 7.6% | 15.7% |
| 资本支出强度资本支出/营收 | 4.9% | 13.3% |
| 现金转化率经营现金流/净利润 | — | 1.81× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $254.8M |
8季度趋势,按日历期对齐
经营现金流
OFIX
PLNT
| Q4 25 | $27.7M | $109.1M | ||
| Q3 25 | $12.4M | $131.5M | ||
| Q2 25 | $11.6M | $44.0M | ||
| Q1 25 | $-18.4M | $133.9M | ||
| Q4 24 | $23.7M | $49.1M | ||
| Q3 24 | $11.7M | $126.8M | ||
| Q2 24 | $9.0M | $78.2M | ||
| Q1 24 | $-18.6M | $89.7M |
自由现金流
OFIX
PLNT
| Q4 25 | $16.8M | $59.0M | ||
| Q3 25 | $2.5M | $76.7M | ||
| Q2 25 | $4.5M | $8.2M | ||
| Q1 25 | $-25.1M | $110.9M | ||
| Q4 24 | $15.2M | $7.0M | ||
| Q3 24 | $6.3M | $78.2M | ||
| Q2 24 | $-360.0K | $40.2M | ||
| Q1 24 | $-29.1M | $63.4M |
自由现金流率
OFIX
PLNT
| Q4 25 | 7.6% | 15.7% | ||
| Q3 25 | 1.2% | 23.2% | ||
| Q2 25 | 2.2% | 2.4% | ||
| Q1 25 | -13.0% | 40.1% | ||
| Q4 24 | 7.0% | 2.1% | ||
| Q3 24 | 3.2% | 26.7% | ||
| Q2 24 | -0.2% | 13.4% | ||
| Q1 24 | -15.4% | 25.6% |
资本支出强度
OFIX
PLNT
| Q4 25 | 4.9% | 13.3% | ||
| Q3 25 | 4.8% | 16.6% | ||
| Q2 25 | 3.5% | 10.5% | ||
| Q1 25 | 3.5% | 8.3% | ||
| Q4 24 | 4.0% | 12.4% | ||
| Q3 24 | 2.7% | 16.6% | ||
| Q2 24 | 4.7% | 12.6% | ||
| Q1 24 | 5.6% | 10.6% |
现金转化率
OFIX
PLNT
| Q4 25 | — | 1.81× | ||
| Q3 25 | — | 2.23× | ||
| Q2 25 | — | 0.76× | ||
| Q1 25 | — | 3.20× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 3.02× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 2.62× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
PLNT
| Corporate Owned Club Segment | $135.6M | 36% |
| Equipment Revenue | $121.2M | 32% |
| Franchise | $98.6M | 26% |
| Advertising | $20.8M | 6% |
| Related Party | $4.3M | 1% |